HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,174.00
+26.00 (2.26%)
At close: Sep 11, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 53.45 billion as of September 11, 2026. Its market cap has decreased by -32.20% in one year.
Market Cap
53.45B
Enterprise Value
35.16B
Revenue
14.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,174.00
ChartMarket Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 53.45B, an increase of 209.14%. That is a compound annual growth rate of 4.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 53.45B | -32.29% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 234.26B |
| 3billion | 136.84B |
| GC Medical Science | 74.41B |
| GENINUS | 71.10B |
| Cytogen | 70.65B |
| Inventera | 68.98B |
| Protia | 67.62B |
| Seoulin Bioscience | 36.62B |